Rupert Vessey - Net Worth and Insider Trading
Rupert Vessey Net Worth
The estimated net worth of Rupert Vessey is at least $3 Million dollars as of 2024-11-13. Rupert Vessey is the EVP & President, Research of Bristol-Myers Squibb Co and owns about 48,407 shares of Bristol-Myers Squibb Co (BMY) stock worth over $3 Million. Rupert Vessey is also the See remarks of Celgene Corp and owns about 285 shares of Celgene Corp (CELG) stock worth over $30,848. Details can be seen in Rupert Vessey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rupert Vessey has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rupert Vessey
Rupert Vessey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rupert Vessey owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , Bio-Techne Corp (TECH) , and Juno Therapeutics Inc (JUNO) .
Click here to see the complete history of Rupert Vessey’s form 4 insider trades.
Insider Ownership Summary of Rupert Vessey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2023-05-03 | Pres. & Research & Early Dev. |
| TECH | Bio-Techne Corp | 2021-10-28 | director |
| JUNO | Juno Therapeutics Inc | 2017-04-13 | director |
Rupert Vessey Latest Holdings Summary
Rupert Vessey currently owns a total of 2 stocks. Among these stocks, Rupert Vessey owns 48,407 shares of Bristol-Myers Squibb Co (BMY) as of May 3, 2023, with a value of $3 Million and a weighting of 98.93%. Rupert Vessey also owns 285 shares of Celgene Corp (CELG) as of June 15, 2017, with a value of $30,848 and a weighting of 1.07%.
Latest Holdings of Rupert Vessey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2023-05-03 | 48,407 | 59.02 | 2,856,981 |
| CELG | Celgene Corp | 2017-06-15 | 285 | 108.24 | 30,848 |
Holding Weightings of Rupert Vessey
Rupert Vessey Form 4 Trading Tracker
According to the SEC Form 4 filings, Rupert Vessey has made a total of 9 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Bristol-Myers Squibb Co is the sale of 50,385 shares on May 3, 2023, which brought Rupert Vessey around $3 Million.
According to the SEC Form 4 filings, Rupert Vessey has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 4,785 shares on June 15, 2017, which brought Rupert Vessey around $575,061.
Insider Trading History of Rupert Vessey
- 1
Rupert Vessey Trading Performance
Rupert Vessey Ownership Network
Ownership Network List of Rupert Vessey
Ownership Network Relation of Rupert Vessey
Rupert Vessey Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Rupert Vessey is the Pres. & Research & Early Dev. of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Rupert Vessey made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 17,986 shares made by Ann Powell Judge , and a net purchase of 8,500 shares made by Samuels Theodore R. Ii .
In summary, during the past 3 months, insiders sold 700 shares of Bristol-Myers Squibb Co (BMY) in total and bought 1,830 shares, with a net purchase of 1,130 shares. During the past 18 months, 19,418 shares of Bristol-Myers Squibb Co (BMY) were sold and 15,401 shares were bought by its insiders, resulting in a net sale of 4,017 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Rupert Vessey Mailing Address
Above is the net worth, insider trading, and ownership report for Rupert Vessey. You might contact Rupert Vessey via mailing address: C/o Celgene Corporation, 86 Morris Avenue, Summit Nj 07901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
